Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRIDER Canada: Sildenafil in Early-Onset Intrauterine Growth Restriction
NCT02442492Phase 3Terminated
- Sponsor
- University of British Columbia
- Start
- Jan 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ASP-001 in fetal growth restriction (FGR), sponsored by University of British Columbia. Started Jan 2017; status: terminated.
02
Drugs
ASP-001
03
Conditions
fetal growth restriction (FGR)
Beyond the preview
Go deeper on NCT02442492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02442492.